Fmoc-Cit-OH,
Fmoc-L-citrulline,
133174-15-9,
Nalpha-Fmoc-L-citrulline,
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-ureidopentanoic acid,
L-Ornithine, N5-(aminocarbonyl)-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-,
MFCD00151943,
J-300338,
Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-citrulline,
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-ureido-pentanoic acid,
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-ureidopentanoic acid,
C21H23N3O5,
fmoc-citoh,
AK-49357,
AC1MBSUX,
PubChem19002,
KSC183O6L,
SCHEMBL119468,
CTK0I3765,
KS-00000ACY,
DTXSID10373252,
NBMSMZSRTIOFOK-SFHVURJKSA-N,
ACT03148,
ZINC2517152,
ANW-19515,
CF-287,
AKOS015837234,
AKOS015895285,
AC-8677,
AM82463,
AN-7798,
CS-W008064,
RTR-004528,
Fmoc-Cit-OH, >=97.0% (HPLC),
AJ-37039,
AS-17492,
BC678176,
BR-49357,
SC-10125,
AB0019870,
AX8001387,
DB-038068,
ST2408263,
TR-004528,
F0626,
FT-0082823,
FT-0643194,
V0425,
M-1069,
M03232,
174F159,
C-21654,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-citrulline,
(2S)-5-(carbamoylamino)-2-(9H-fluoren-9-ylmethoxycarbonylamino)pentanoic acid,
(2S)-5-(carbamoylamino)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pentanoic acid,
AIDS212176,
ACN-033817,
CID2756127,
A7487,